This inventor holds 1 USPTO granted patent. Top assignee: Zamboni Chem Solutions Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations of Ryan Henning in Cancer Treatment
Introduction
Ryan Henning is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative work. His research focuses on developing compounds that can effectively target and degrade RAF proteins, which are implicated in various cancers.
Latest Patents
Ryan Henning holds a patent for RAF-degrading conjugate compounds. This patent outlines the utility of these compounds in treating cancer and other diseases related to RAF. The disclosure includes pharmaceutical compositions, methods of treatment, and kits that incorporate the RAF-degrading conjugate compounds.
Career Highlights
Ryan is associated with Zamboni Chem Solutions Inc., where he applies his expertise in medicinal chemistry. His work has the potential to lead to groundbreaking therapies for patients suffering from RAF-related diseases. With one patent to his name, he is recognized for his innovative approach to cancer treatment.
Collaborations
Ryan collaborates with notable colleagues, including Robert J. Zamboni and Xian Alan Ji. Their combined efforts contribute to the advancement of research in the field of oncology.
Conclusion
Ryan Henning's innovative work in developing RAF-degrading conjugate compounds represents a significant advancement in cancer treatment. His contributions have the potential to improve therapeutic options for patients facing challenging diagnoses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile